NONMEM Users Network Archive

Hosted by Cognigen

[NMusers] Job Opportunity: Senior Scientist Pharmacometrician

From: kosalaram Goteti <>
Date: Thu, 4 Apr 2019 21:14:39 +0000 (UTC)

 EMD Serono is seeking one creative, motivatedPharmacometrician t=
o join its Pharmacometric team in its US HQ of Billerica (Boston, USA)=

To apply, please visit
WhoWe Are:
EMD Serono is the North American biopharma brand ofMerck KGaA, Darmstadt, G=
ermany - a leading science and technology company -focused exclusively on s=
pecialty care. For more than 40 years, the brand hasintegrated cutting-edge=
 science, innovative products and industry-leadingpatient support and acces=
s programs. EMD Serono has deep expertise inneurology, fertility and endocr=
inology, as well as a robust pipeline ofpotential therapies in oncology, im=
muno-oncology and immunology as R&Dfocus areas.
At EMD Serono the Pharmacometrics Department, part of Translational Medicin=
e/Quantitative Pharmacology, contributes to clinical development efficiency=
 by providing core expertise modeling in the quantification of the relation=
ship between dose, exposure and response, and factors affecting its variabi=
   - Elaborate, design, execute and report pharmacokinetic/pharmacodynamic =
   - Utilize modeling and simulation analysis to support model informed dru=
g development discovery.
   - Collaborate with pharmacology, clinical team and biostatistics teams.
   - Keep up-to-date with scientific development in PK/PD and share one=
s own expertise with pharmacometrics colleagues.
Whoyou are:
Minimum Qualifications:
   - Bachelor’s degree plus 3 years of experience or Master=
s degree
   - Experience with modeling and simulation software such as NONMEM, R or =
Preferred Qualifications:
   - A PhD, MD, PharmD or Master’s degree with a minimum of 2 plus =
year’s experience in PK/PD modeling, with experience in (Bio)Pharma=
ceutical Industry is strongly desired
   - Experience with at least one the following software, XPose, PsN, MONOL=
IX, SIMULX, SIMCYP, MATLAB or similar pharmacometrics modeling and simulati=
on software is a plus.
   - Ability to communicate technical results and details effectively with =
scientists and clinicians.
   - Experience working in a dynamic matrixed organization.
   - Ability to be a team player and work cross functionally.
   - Fluency in speaking and writing English; fluency in other languages is=
 an asset.
What weoffer: 
Your possibilities to develop in our growing company are just asmanifold as=
 our product portfolio. We offer a modern and international workingenvironm=
ent to unleash your innovative potential in diverse teams, and takeresponsi=
bility for our employees, products, the environment and society. EMD S=
erono isan Equal Employment Opportunity employer. No employee or applicant =
foremployment will be discriminated against on the basis of race, color, re=
ligion,age, sex, sexual orientation, national origin, ancestry, disability,=
 militaryor veteran status, genetic information, gender identity, transgend=
er status,marital status, or any other classification protected by applicab=
le federal,state, or local law.  This policy ofEqual Employment Opport=
unity applies to all policies and programs relating torecruitment and hirin=
g, promotion, compensation, benefits, discipline,termination, and all other=
 terms and conditions of employment. Any applicant oremployee who believes =
they have been discriminated against by the Company oranyone acting on beha=
lf of the Company must report any concerns to his/herHuman Resources Busine=
ss Partner, Legal, or Compliance immediately. The Companywill not retaliate=
 against any individual because he/she made a good faithreport of discrimin=

   - With best regards, 
Kosalaram Goteti, Director, Site Head ofPharmacometry (Billerica)=
Pascal Girard,Senior Scientific Director, Global Head of Pharmacometry

Received on Thu Apr 04 2019 - 17:14:39 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to: Once subscribed, you may contribute to the discussion by emailing: